Understanding and managing atherosclerotic renovascular disease: still a work in progress [version 1; referees: 4 approved]
Atherosclerotic renovascular disease (ARVD) is an unresolved therapeutic dilemma despite extensive pre-clinical and clinical studies. The pathophysiology of the disease has been widely studied, and many factors that may be involved in progressive renal injury and cardiovascular risk associated with...
Main Author: | Alejandro R. Chade |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-11-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1862/v1 |
Similar Items
-
Resistant hypertension in atherosclerotic renovascular disease
by: Angelo Bosio, et al.
Published: (2015-10-01) -
Progress toward an integrated understanding of Parkinson's disease [version 1; referees: 2 approved]
by: Maxime W.C. Rousseaux, et al.
Published: (2017-07-01) -
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease [version 1; referees: 2 approved]
by: Michael D. Shapiro, et al.
Published: (2017-02-01) -
Atherosclerotic renovascular disease – epidemiology, treatment and current challenges
by: Diana Vassallo, et al.
Published: (2017-09-01) -
Recent advances in understanding Streptomyces [version 1; referees: 4 approved]
by: Keith F. Chater
Published: (2016-11-01)